JNJ241122P146000
- 0.07
- -0.11-61.11%
Johnson & Johnson Newsroom
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Express News | J&J: He Phase 3 Iconic-Psa Program Which Will Investigate Icotrokinra in Psoriatic Arthritis Will Be Initiated in the Beginning of 2025
Johnson & Johnson Announced Topline Results From ICONIC-LEAD, A Pivotal Phase 3 Investigational Study Of Icotrokinra, The First Targeted Oral Peptide That Selectively Blocks The IL-23 Receptor, In Adults And Adolescents 12 Years Of Age And Older With...
Express News | Johnson & Johnson - 74% of Patients Achieved Clear or Almost Clear Skin at Week 24
Express News | Johnson & Johnson - Icotrokinra Meets Co-Primary Endpoints in Phase 3 Study
Express News | Icotrokinra Delivered an Industry-Leading Combination of Significant Skin Clearance With Demonstrated Tolerability in a Once Daily Pill in Phase 3 Topline Results
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
Johnson & Johnson (JNJ) Management Presents at Stifel 2024 Healthcare Conference (Transcript)
Monday Opens to S&P 500 Climb, Dow Slides as Eyes Look Toward Nvidia | Live Stock
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
US Manufacturing Index Rises To 43, Highest Since 2020
Income Investing: Cast a Wider Net With These High-Yield Dividend Aristocrats -- Barron's
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says